Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mary Linton B, Peters"'
Autor:
Zachary M. Avigan, Rodrigo Paredes, Leora S. Boussi, Barbara D. Lam, Meghan E. Shea, Matthew J. Weinstock, Mary Linton B. Peters
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16869-16875 (2023)
Abstract Background COVID‐19 infection delays therapy and in‐person evaluation for oncology patients, but clinic clearance criteria are not clearly defined. Methods We conducted a retrospective review of oncology patients with COVID‐19 at a ter
Externí odkaz:
https://doaj.org/article/999cfb75f72d42109be867ff66f52fca
Autor:
Wenxin Xu, Andrew J. Piper‐Vallillo, Poorva Bindal, Jonathan Wischhusen, Jaymin M. Patel, Daniel B. Costa, Mary Linton B. Peters
Publikováno v:
Cancer Medicine, Vol 10, Iss 5, Pp 1545-1549 (2021)
Abstract Background For cancer patients, coronavirus disease 19 (COVID‐19) infection can lead to delays in cancer therapy both due to the infection itself and due to the need to minimize exposure to other patients and to staff. Clearance guidelines
Externí odkaz:
https://doaj.org/article/5ac4ba386cfc4f03ad6ccca2cd4c4b48
Autor:
Amir T. Fathi, Geoffrey G Fell, Areej El-Jawahri, Alexander E. Perl, Brian A. Jonas, Ajoy L. Dias, Alice S. Mims, Uma Borate, Brittany Knick Ragon, Michael R. Grunwald, Mary Linton B. Peters, Timothy A. Graubert, Philip C. Amrein, Hanno R. Hock, Andrew M. Brunner, Gabriela S. Hobbs, Rupa Narayan, Donna S. Neuberg, Ibrahim Aldoss
Publikováno v:
Blood. 140:3284-3286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0461e29c8969a9415f041ed1cdf043c5
https://doi.org/10.1182/blood-2022-162525
https://doi.org/10.1182/blood-2022-162525
Autor:
Peter P. Mueller, Qiushi Chen, Turgay Ayer, Gizem S. Nemutlu, Ali Hajjar, Emily D. Bethea, Mary Linton B. Peters, Brian P. Lee, Naveed Z. Janjua, Fasiha Kanwal, Jagpreet Chhatwal
Publikováno v:
J Hepatol
BACKGROUND & AIMS: Successful treatment of chronic hepatitis C with oral direct-acting antivirals (DAAs) leads to virological cure, however, the subsequent risk of hepatocellular carcinoma (HCC) persists. Our objective was to evaluate the cost-effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::099f2eb8495272467ac4ae5d8a6d167d
https://doi.org/10.1016/j.jhep.2022.01.027
https://doi.org/10.1016/j.jhep.2022.01.027
Autor:
Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo, Karen Zhang, Apurva Jain, Anaemy Danner De Armas, Stephanie Reyes, Tri Minh Le, Osama E Rahma, Jennifer Stanton, Thomas T DeLeon, Marc Roth, Mary Linton B Peters, Andrew X Zhu, Jochen K Lennerz, A John Iafrate, Kylie Boyhen, Christine VanCott, Lewis R Roberts, Stacie Lindsey, Nora Horick, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Robin Kate Kelley, Milind M Javle, Lipika Goyal
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background Treatment patterns for intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC) differ, but limited studies exist comparing them. This study examines differences in molecular profiling rates and treatment patterns in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59fed0ded0ad5d9fea96d8acc42ee918
https://doi.org/10.1093/jnci/djad046
https://doi.org/10.1093/jnci/djad046
Autor:
Manuel Hidalgo, Senthil K. Muthuswamy, Mark Callery, Tara S. Kent, Martin Smith, Tyler M. Berzin, Douglas Pleskow, Mandeep S. Sawhney, Robert Besaw, Roger B. Davis, Christine Lim, Supraja Narasimhan, Catherine Conahan, Mary Linton B. Peters, Benjamin Schlechter, Andrea J. Bullock, Bruno Bockorny, Jonah Cohen, Leo L. Tsai, Raul S. Gonzalez, Sofia Perea, Dipikaa Akshinthala, Ling Huang, Lakshmi Muthuswamy, Joseph E. Grossman
Supplementary Data from Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1260fc09a1c2717a2c1423956de7284d
https://doi.org/10.1158/1078-0432.22484078
https://doi.org/10.1158/1078-0432.22484078
Autor:
Manuel Hidalgo, Senthil K. Muthuswamy, Mark Callery, Tara S. Kent, Martin Smith, Tyler M. Berzin, Douglas Pleskow, Mandeep S. Sawhney, Robert Besaw, Roger B. Davis, Christine Lim, Supraja Narasimhan, Catherine Conahan, Mary Linton B. Peters, Benjamin Schlechter, Andrea J. Bullock, Bruno Bockorny, Jonah Cohen, Leo L. Tsai, Raul S. Gonzalez, Sofia Perea, Dipikaa Akshinthala, Ling Huang, Lakshmi Muthuswamy, Joseph E. Grossman
Purpose:Pancreatic ductal adenocarcinoma (PDAC) remains a significant health issue. For most patients, there are no options for targeted therapy, and existing treatments are limited by toxicity. The HOPE trial (Harnessing Organoids for PErsonalized T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c2c3cab84e98173ebbc1888ec47fd08
https://doi.org/10.1158/1078-0432.c.6531320
https://doi.org/10.1158/1078-0432.c.6531320
Autor:
Lakshmi Muthuswamy, Ling Huang, Raul S. Gonzalez, Jonah Cohen, Senthil K. Muthuswamy, Catherine Conahan, Supraja Narasimhan, Tyler M. Berzin, Mandeep S. Sawhney, Andrea J. Bullock, Mary Linton B. Peters, Sofia Perea, Roger B. Davis, Benjamin Schlechter, Bruno Bockorny, Dipikaa Akshinthala, Robert J. Besaw, Mark P. Callery, Douglas K. Pleskow, Leo L. Tsai, Martin P. Smith, Christine Maria Lim, Manuel Hidalgo, Tara S. Kent, Joseph E. Grossman
Publikováno v:
Clin Cancer Res
Purpose: Pancreatic ductal adenocarcinoma (PDAC) remains a significant health issue. For most patients, there are no options for targeted therapy, and existing treatments are limited by toxicity. The HOPE trial (Harnessing Organoids for PErsonalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a528f7d154a6854e7926499da596a9af
https://doi.org/10.1158/1078-0432.ccr-20-4116
https://doi.org/10.1158/1078-0432.ccr-20-4116
Publikováno v:
Ann Intern Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba030921d8712b124f0f23fb13432fc4
https://pubmed.ncbi.nlm.nih.gov/34781710
https://pubmed.ncbi.nlm.nih.gov/34781710
Autor:
Mary Linton B. Peters, Andrew Eckel, Anna Lietz, Claudia Seguin, Peter Mueller, Chin Hur, Pari V. Pandharipande
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 22(6)
First-degree relatives (FDRs) of patients with pancreatic ductal adenocarcinoma (PDAC) have elevated PDAC risk, partially due to germline genetic variants. We evaluated the potential effectiveness of genetic testing to target MRI-based screening amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0013b544c4f631fe9790948c6bb0649
https://pubmed.ncbi.nlm.nih.gov/35752568
https://pubmed.ncbi.nlm.nih.gov/35752568